NLST's request for their patent re-certification "in the mail":
PATENT: 95/001,339 Filing or 371 (c) Date: 06-08-2010 Status: Terminated; released to Publications for issuance of Reexam Certificate Status Date: 12-30-2020
My take on these "free" shares: CEO salary $790K, CFO $424K they both sell shares to beef up their income. This process has been a long haul. I know of bio CEO's (also long hauls) $MMs in salaries + MMs in "free" shrs + going into debt and diluting to pay those salaries with no approved drug or approved drug does not live up the expectations. I'm not unhappy about the form 4s and I look at the 4 yr time span for CEO payout as a good sign.
When the uspto publishes the recertification (supposed to be about 2 weeks as uspto already posted "sent to publishing") they are free to file for Stay lift. The stock has been slowly climbing since the covid crash followed by some sideways.